Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 44 for “"Activated B cell"”.

  1. Development of a Burkitt Lymphoma cell line with inducible expression of activated B-cell factor-1

    Activated B-cell Factor-I (ABF-1) is a class II basic helix-loop-helix protein expressed in activated B-cells, EBV -immortalized lymphoblastoid cell lines and embryonic skeletal muscle in mice. ABF -1 dimerizes with another bHLH protein E4 7 to form a transcriptional repressor ofE2A, which is a …

    u-pacific Repository record for Development of a Burkitt Lymphoma cell line with inducible expression of activated B-cell factor-1 (opens in a new tab)

  2. Development of a human plasmacytoma cell line with inducible expression of activated B-cell factor-1

    The basic helix-loop-helix protein, activated B-cell factor-l (ABF-l), is a transcription factor involved in cellular proliferation and differentiation. ABF-1 shows patterns of expression that are stimulated in activated B cells, which may suggest ABF-1 is involved in the regulation of B-cell …

    u-pacific Repository record for Development of a human plasmacytoma cell line with inducible expression of activated B-cell factor-1 (opens in a new tab)

  3. The Role of Pag1 In The Activated B-Cell Subtype of Diffuse Large B-Cell Lymphoma

    Diffuse Large B Cell Lymphoma (DLBCL) is the most common aggressive hematologic malignancy in adults, but despite recent advances in treatment, many patients today still face poor outcomes. Of the two types of DLBCL, activated B-cell (ABC) and germinal center B-cell (GCB), patients diagnosed with …

    uthsc Repository record for The Role of Pag1 In The Activated B-Cell Subtype of Diffuse Large B-Cell Lymphoma (opens in a new tab)

  4. Investigating the Effects of CD40-CD40 Ligand on Activated B Cell Diffuse Large B Cell Lymphoma B Cell Receptor Signaling

    Activated B cell-like diffuse large B-cell lymphoma (ABC-DLBCL), one of the more aggressive forms of non-Hodgkin lymphoma, accounts for one-third of all DLBCL cases. There is an urgent need to develop new therapeutic interventions, as 40% of patients either relapse after an initial response or do …

    gatech Repository record for Investigating the Effects of CD40-CD40 Ligand on Activated B Cell Diffuse Large B Cell Lymphoma B Cell Receptor Signaling (opens in a new tab)

  5. The utilization of activated B cell for cell carrier for viral vectored antigen delivery in the acceleration of CD8 T cell recall response

    … responses to treat tumor. In particular, CD8+ T cells have the unique capacity to recognize and destroy tumor cell throughout the body. One potential approach to elicit high numbers of effector CD8+ T cells to control tumor growth is through repeated vaccination, a strategy called prime-boost …

    mcmaster Repository record for The utilization of activated B cell for cell carrier for viral vectored antigen delivery in the acceleration of CD8 T cell recall response (opens in a new tab)

  6. Novel modalities of T and B lymphocyte migration

    IL-17-producing helper T (Th17) cells are critical for host defense against extracellular pathogens but also drive numerous autoimmune diseases. Th17 cells that differ in their inflammatory potential have been described including IL-10-producing Th17 cells that are weak inducers of inflammation and …

    adelaide Repository record for Novel modalities of T and B lymphocyte migration (opens in a new tab)

  7. The Role of Membrane Protein Phosphorylation in Mitogen and Interleukin Four Mediated Activation of Murine B Lymphocytes

    … to result in phosphorylation of a number of celluilar proteins. Lymphocyte activation by anti-Ig or TPA results in an increase in tyrosine phosphorylation of human B cell membrane proteins, thus implicating tyrosine kinase activities in the transmission of lymphocyte activation signals. In …

    glasgow Download PDF for The Role of Membrane Protein Phosphorylation in Mitogen and Interleukin Four Mediated Activation of Murine B Lymphocytes (opens in a new tab)

  8. Characterising hepatic B cell subsets in human chronic liver disease

    B cells have been proven to have a significant role in liver fibrosis. We postulate that enrichment of B cell subsets in hepatic diseases may implicate this population in liver pathogenesis. When comparing total B cells from human immune and non-immune-mediated liver disease explants, we found an …

    birmingham Download PDF for Characterising hepatic B cell subsets in human chronic liver disease (opens in a new tab)

  9. The role of lyp phosphatase in primary human macrophages AND cRel and its effect on class switch recombination, IRF4 induction and plasma cell differentiation during a T-independent immune response

    … The NFκB member, cRel, is important in activated B cell proliferation, survival and also in class switch recombination (CSR) and IRF4 induction in vitro. IRF4 is essential in plasma cell differentiation as well as CSR. We found that after NP-Ficoll immunisation of mice, cRel -/- (KO) B …

    birmingham Download PDF for The role of lyp phosphatase in primary human macrophages AND cRel and its effect on class switch recombination, IRF4 induction and plasma cell differentiation during a T-independent immune response (opens in a new tab)

  10. THE SECOND GENERATION PROTEASOME INHIBITOR CARFILZOMIB INTERACTS SYNERGISTICALLY WITH HDAC INHIBITORS IN DIFFUSE LARGE B-CELL LYMPHOMA CELLS THROUGH MULTIPLE MECHANISMS AND CIRCUMVENTS BORTEZOMIB RESISTANCE

    … were examined in both germinal center (GC) and activated B-cell (ABC) subtypes of human diffuse large B-cell lymphoma (DLBCL). Simultaneous exposure to minimally toxic concentrations of carfilzomib and HDAC inhibitor vorinostat resulted in the release of mitochondrial pro-apoptotic proteins SMAC …

    vcu Repository record for THE SECOND GENERATION PROTEASOME INHIBITOR CARFILZOMIB INTERACTS SYNERGISTICALLY WITH HDAC INHIBITORS IN DIFFUSE LARGE B-CELL LYMPHOMA CELLS THROUGH MULTIPLE MECHANISMS AND CIRCUMVENTS BORTEZOMIB RESISTANCE (opens in a new tab)

  11. Study of the Effect of B-Cell-Intrinsic Mhcii Antigen Presentation on Germinal Center B Cell Evolution Using The Brainbow Mouse Model

    … (MHCII) are molecules that are essential for B cell activation, as well as clonal competition among activated B cell clones during germinal center (GC) reactions. However, it is unknown to what extent MHCII drives the selection of some clones over others. This is of particular importance since …

    south-carolina Repository record for Study of the Effect of B-Cell-Intrinsic Mhcii Antigen Presentation on Germinal Center B Cell Evolution Using The Brainbow Mouse Model (opens in a new tab)

  12. A Role for INF-ɣ-Inducble Transcription Factors in Antibody Secreting Cell Differentiation

    … (IFN)-ɣ-driven inflammatory microenvironment, B cells may produce antibody which is critical for rapid viral clearance and continued protection from reinfection. However, the roles of IFN-ɣ and IFN-ɣ-induced transcription factors (TFs) in driving antibody secreting cell (ASC) development from …

    uab Repository record for A Role for INF-ɣ-Inducble Transcription Factors in Antibody Secreting Cell Differentiation (opens in a new tab)

  13. Targeting Epigenetic Regulators For The Treatment of Diffuse Large B-Cell Lymphoma

    … promise for the treatment of Germinal Center B-Cell-like Diffuse Large B-Cell Lymphoma (GCB-DLBCL). Compared to a 60% Objective Response Rate (ORR) in Phase I clinical trials, Phase II trial results for the EZH2 inhibitor EPZ-6438 reported an attenuation of response. Mechanisms contributing to …

    uthsc Repository record for Targeting Epigenetic Regulators For The Treatment of Diffuse Large B-Cell Lymphoma (opens in a new tab)

  14. Myd88 is required for haematopoietic development in Drosophila

    … characterised to transmit immune signals from activated Toll-like receptor (TLR) or Interleukin-1 (IL-1) receptor to the NF-kB pathway. The Toll pathway was first identified in Drosophila, which led to the subsequent discovery of the analogous Toll-like Receptor (TLR) pathway in mammals. …

    anu Repository record for Myd88 is required for haematopoietic development in Drosophila (opens in a new tab)

  15. Ο φαινότυπος και η μετάδοση του ενδοκυττάριου μηνύματος των Β λεμφοκυττάρων σε ασθενείς με συστηματική σκληροδερμία

    … the study was to explore the phenotype and intracellular signaling events of B cells in patients with systemic sclerosis (SSc). Peripheral blood B cell surface markers CD19 and CD22 were evaluated by flow cytometry in 23 patients with SSc and seven healthy individuals. Levels of intracellular …

    greece Repository record for Ο φαινότυπος και η μετάδοση του ενδοκυττάριου μηνύματος των Β λεμφοκυττάρων σε ασθενείς με συστηματική σκληροδερμία (opens in a new tab)

  16. ONCOGENIC CARD11 DRIVES B CELL EXPANSION BY POTENTIATING NONCANONICAL NF-KAPPAB SIGNALING

    … implicated in a variety of lymphomas, including activated B cell-like (ABC) subtype of Diffuse Large B cell Lymphoma (DLBCL), where they bypass normal regulation and signal constitutively. To analyze the effect of GOF CARD11 on lymphomagenesis, we generated knockin mice expressing either the …

    jhu Repository record for ONCOGENIC CARD11 DRIVES B CELL EXPANSION BY POTENTIATING NONCANONICAL NF-KAPPAB SIGNALING (opens in a new tab) Embargoed until 2028-12-01

  17. Validation of lymphoma-associated antigens identified using autoantibody profiling and protein arrays

    <p>Diffuse large B-cell lymphoma (DLBCL) is an aggressive lymphoma subtype with heterogeneous clinical outcome and a significant number of patients still die of their disease. Characterising lymphoma patients’ autoantibody repertoires represent one approach to improve the understanding of their …

    oxford Repository record for Validation of lymphoma-associated antigens identified using autoantibody profiling and protein arrays (opens in a new tab)

  18. Targeting X-linked Inhibitor of Apoptosis Protein to Overcome Rituximab/Chemotherapy Resistance in B-cell Lymphomas

    … Overcome Rituximab/ Chemotherapy Resistance in B-Cell Lymphomas.The addition of Rituximab to front-line therapy has improved clinical outcomes in diffuse large B-cell lymphoma (DLBCL), but it has also altered the biology of relapsed/refractory disease. To better understand the mechanisms …

    buffalo Repository record for Targeting X-linked Inhibitor of Apoptosis Protein to Overcome Rituximab/Chemotherapy Resistance in B-cell Lymphomas (opens in a new tab)

Page 1 of 3